{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:12:16Z","timestamp":1790644336308,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T00:00:00Z","timestamp":1547424000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"crossref","award":["GRF_17110715"],"award-info":[{"award-number":["GRF_17110715"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"crossref","award":["GRF_17114817"],"award-info":[{"award-number":["GRF_17114817"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["GRF_17123016"],"award-info":[{"award-number":["GRF_17123016"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003802","name":"University Research Committee, University of Hong Kong","doi-asserted-by":"publisher","award":["201409176166"],"award-info":[{"award-number":["201409176166"]}],"id":[{"id":"10.13039\/501100003802","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003802","name":"University Research Committee, University of Hong Kong","doi-asserted-by":"crossref","award":["201711159209"],"award-info":[{"award-number":["201711159209"]}],"id":[{"id":"10.13039\/501100003802","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13046-018-0998-6","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T04:14:04Z","timestamp":1547439244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["SOX9 is a dose-dependent metastatic fate determinant in melanoma"],"prefix":"10.1186","volume":"38","author":[{"given":"Xintao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Aijia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May Pui Lai","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"On Ying","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yuan","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Lok","family":"Lung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3471-8534","authenticated-orcid":false,"given":"Martin","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,14]]},"reference":[{"issue":"1","key":"998_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5\u201329.","journal-title":"CA Cancer J Clin"},{"key":"998_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-genom-091212-153429","volume":"14","author":"VK Hill","year":"2013","unstructured":"Hill VK, Gartner JJ, Samuels Y, Goldstein AM. The genetics of melanoma: recent advances. Annu Rev Genomics Hum Genet. 2013;14:257\u201379.","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"6","key":"998_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ctrv.2015.04.010","volume":"41","author":"P Queirolo","year":"2015","unstructured":"Queirolo P, Picasso V, Spagnolo F. Combined BRAF and MEK inhibition for the treatment of BRAF-mutated metastatic melanoma. Cancer Treat Rev. 2015;41(6):519\u201326.","journal-title":"Cancer Treat Rev"},{"key":"998_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/OTT.S39096","volume":"8","author":"F Spagnolo","year":"2015","unstructured":"Spagnolo F, Ghiorzo P, Orgiano L, Pastorino L, Picasso V, Tornari E, et al. BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies. Onco Targets Ther. 2015;8:157\u201368.","journal-title":"Onco Targets Ther"},{"issue":"25","key":"998_CR5","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1038\/onc.2014.262","volume":"34","author":"M Ennen","year":"2015","unstructured":"Ennen M, Keime C, Kobi D, Mengus G, Lipsker D, Thibault-Carpentier C, et al. Single-cell gene expression signatures reveal melanoma cell heterogeneity. Oncogene. 2015;34(25):3251\u201363.","journal-title":"Oncogene"},{"issue":"23","key":"998_CR6","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.1242\/dev.00808","volume":"130","author":"M Cheung","year":"2003","unstructured":"Cheung M, Briscoe J. Neural crest development is regulated by the transcription factor Sox9. Development. 2003;130(23):5681\u201393.","journal-title":"Development"},{"issue":"1","key":"998_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/ng0198-60","volume":"18","author":"EM Southard-Smith","year":"1998","unstructured":"Southard-Smith EM, Kos L, Pavan WJ. Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat Genet. 1998;18(1):60\u20134.","journal-title":"Nat Genet"},{"issue":"8","key":"998_CR8","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1073\/pnas.1211747110","volume":"110","author":"JA Liu","year":"2013","unstructured":"Liu JA, Wu MH, Yan CH, Chau BK, So H, Ng A, et al. Phosphorylation of Sox9 is required for neural crest delamination and is regulated downstream of BMP and canonical Wnt signaling. Proc Natl Acad Sci U S A. 2013;110(8):2882\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"998_CR9","unstructured":"Liu JA, Cheung M. Neural crest stem cells and their potential therapeutic applications. Dev. Biol. 2016;419(2):199\u2013216."},{"issue":"2","key":"998_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.devcel.2004.12.010","volume":"8","author":"M Cheung","year":"2005","unstructured":"Cheung M, Chaboissier MC, Mynett A, Hirst E, Schedl A, Briscoe J. The transcriptional control of trunk neural crest induction, survival, and delamination. Dev Cell. 2005;8(2):179\u201392.","journal-title":"Dev Cell"},{"issue":"2","key":"998_CR11","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/dvdy.20341","volume":"233","author":"SJ McKeown","year":"2005","unstructured":"McKeown SJ, Lee VM, Bronner-Fraser M, Newgreen DF, Farlie PG. Sox10 overexpression induces neural crest-like cells from all dorsoventral levels of the neural tube but inhibits differentiation. Dev Dyn. 2005;233(2):430\u201344.","journal-title":"Dev Dyn"},{"issue":"7","key":"998_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003644","volume":"9","author":"ML Harris","year":"2013","unstructured":"Harris ML, Buac K, Shakhova O, Hakami RM, Wegner M, Sommer L, et al. A dual role for SOX10 in the maintenance of the postnatal melanocyte lineage and the differentiation of melanocyte stem cell progenitors. PLoS Genet. 2013;9(7):e1003644.","journal-title":"PLoS Genet"},{"issue":"4","key":"998_CR13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1755-148X.2010.00711.x","volume":"23","author":"ML Harris","year":"2010","unstructured":"Harris ML, Baxter LL, Loftus SK, Pavan WJ. Sox proteins in melanocyte development and melanoma. Pigment Cell Melanoma Res. 2010;23(4):496\u2013513.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"2","key":"998_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1006\/dbio.2001.0372","volume":"237","author":"SB Potterf","year":"2001","unstructured":"Potterf SB, Mollaaghababa R, Hou L, Southard-Smith EM, Hornyak TJ, Arnheiter H, et al. Analysis of SOX10 function in neural crest-derived melanocyte development: SOX10-dependent transcriptional control of dopachrome tautomerase. Dev Biol. 2001;237(2):245\u201357.","journal-title":"Dev Biol"},{"issue":"8","key":"998_CR15","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/bies.20445","volume":"28","author":"RN Kelsh","year":"2006","unstructured":"Kelsh RN. Sorting out Sox10 functions in neural crest development. BioEssays. 2006;28(8):788\u201398.","journal-title":"BioEssays"},{"issue":"18","key":"998_CR16","doi-asserted-by":"publisher","first-page":"5709","DOI":"10.1158\/0008-5472.CAN-12-4620","volume":"73","author":"JC Cronin","year":"2013","unstructured":"Cronin JC, Watkins-Chow DE, Incao A, Hasskamp JH, Schonewolf N, Aoude LG, et al. SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesis. Cancer Res. 2013;73(18):5709\u201318.","journal-title":"Cancer Res"},{"issue":"1","key":"998_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004877","volume":"11","author":"O Shakhova","year":"2015","unstructured":"Shakhova O, Cheng P, Mishra PJ, Zingg D, Schaefer SM, Debbache J, et al. Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma. PLoS Genet. 2015;11(1):e1004877.","journal-title":"PLoS Genet"},{"issue":"4","key":"998_CR18","first-page":"954","volume":"119","author":"T Passeron","year":"2009","unstructured":"Passeron T, Valencia JC, Namiki T, Vieira WD, Passeron H, Miyamura Y, et al. Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid. J Clin Invest. 2009;119(4):954\u201363.","journal-title":"J Clin Invest"},{"issue":"8","key":"998_CR19","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1038\/jid.2014.128","volume":"134","author":"SA Graf","year":"2014","unstructured":"Graf SA, Busch C, Bosserhoff AK, Besch R, Berking C. SOX10 promotes melanoma cell invasion by regulating melanoma inhibitory activity. J Invest Dermatol. 2014;134(8):2212\u201320.","journal-title":"J Invest Dermatol"},{"key":"998_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13059-015-0594-4","volume":"16","author":"PF Cheng","year":"2015","unstructured":"Cheng PF, Shakhova O, Widmer DS, Eichhoff OM, Zingg D, Frommel SC, et al. Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma. Genome Biol. 2015;16:42.","journal-title":"Genome Biol"},{"issue":"4","key":"998_CR21","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/jid.2008.316","volume":"129","author":"A Flammiger","year":"2009","unstructured":"Flammiger A, Besch R, Cook AL, Maier T, Sturm RA, Berking C. SOX9 and SOX10 but not BRN2 are required for nestin expression in human melanoma cells. J Invest Dermatol. 2009;129(4):945\u201353.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"998_CR22","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41467-017-01107-0","volume":"8","author":"JA Liu","year":"2017","unstructured":"Liu JA, Rao Y, Cheung MPL, Hui MN, Wu MH, Chan LK, et al. Asymmetric localization of DLC1 defines avian trunk neural crest polarity for directional delamination and migration. Nat Commun. 2017;8(1):1185.","journal-title":"Nat Commun"},{"issue":"4","key":"998_CR23","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.neuroscience.2009.05.035","volume":"162","author":"JB Aquino","year":"2009","unstructured":"Aquino JB, Lallemend F, Marmigere F, Adameyko II, Golemis EA, Ernfors P. The retinoic acid inducible Cas-family signaling protein Nedd9 regulates neural crest cell migration by modulating adhesion and actin dynamics. Neuroscience. 2009;162(4):1106\u201319.","journal-title":"Neuroscience"},{"issue":"23","key":"998_CR24","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1038\/onc.2010.632","volume":"30","author":"Y Li","year":"2011","unstructured":"Li Y, Bavarva JH, Wang Z, Guo J, Qian C, Thibodeau SN, et al. HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression. Oncogene. 2011;30(23):2633\u201343.","journal-title":"Oncogene"},{"issue":"7050","key":"998_CR25","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature03799","volume":"436","author":"AJ Minn","year":"2005","unstructured":"Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, et al. Genes that mediate breast cancer metastasis to lung. Nature. 2005;436(7050):518\u201324.","journal-title":"Nature"},{"issue":"12","key":"998_CR26","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/sj.onc.1209199","volume":"25","author":"M Natarajan","year":"2006","unstructured":"Natarajan M, Stewart JE, Golemis EA, Pugacheva EN, Alexandropoulos K, Cox BD, et al. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Oncogene. 2006;25(12):1721\u201332.","journal-title":"Oncogene"},{"issue":"10","key":"998_CR27","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1158\/0008-5472.CAN-09-2110","volume":"70","author":"SH Kim","year":"2010","unstructured":"Kim SH, Xia D, Kim SW, Holla V, Menter DG, Dubois RN. Human enhancer of filamentation 1 is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells. Cancer Res. 2010;70(10):4054\u201363.","journal-title":"Cancer Res"},{"issue":"7","key":"998_CR28","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.cell.2006.06.008","volume":"125","author":"M Kim","year":"2006","unstructured":"Kim M, Gans JD, Nogueira C, Wang A, Paik JH, Feng B, et al. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell. 2006;125(7):1269\u201381.","journal-title":"Cell"},{"issue":"3","key":"998_CR29","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.cell.2008.09.043","volume":"135","author":"V Sanz-Moreno","year":"2008","unstructured":"Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S, et al. Rac activation and inactivation control plasticity of tumor cell movement. Cell. 2008;135(3):510\u201323.","journal-title":"Cell"},{"issue":"Pt 7","key":"998_CR30","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1242\/jcs.101444","volume":"125","author":"J Ahn","year":"2012","unstructured":"Ahn J, Sanz-Moreno V, Marshall CJ. The metastasis gene NEDD9 product acts through integrin beta3 and Src to promote mesenchymal motility and inhibit amoeboid motility. J Cell Sci. 2012;125(Pt 7):1814\u201326.","journal-title":"J Cell Sci"},{"issue":"7","key":"998_CR31","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1158\/0008-5472.CAN-13-0920","volume":"74","author":"MJ Domingues","year":"2014","unstructured":"Domingues MJ, Rambow F, Job B, Papon L, Liu W, Larue L, et al. beta-catenin inhibitor ICAT modulates the invasive motility of melanoma cells. Cancer Res. 2014;74(7):1983\u201395.","journal-title":"Cancer Res"},{"issue":"6","key":"998_CR32","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/cup.12473","volume":"42","author":"ME Danga","year":"2015","unstructured":"Danga ME, Yaar R, Bhawan J. Melan-A positive dermal cells in malignant melanoma in situ. J Cutan Pathol. 2015;42(6):388\u201393.","journal-title":"J Cutan Pathol"},{"issue":"8","key":"998_CR33","first-page":"1658","volume":"6","author":"R Guo","year":"2013","unstructured":"Guo R, Franco-Palacios M, Russell M, Goddard L, Hassell L, Gillies E, et al. Micropthalmia transcription factor (MITF) as a diagnostic marker for metastatic melanomas negative for other melanoma markers. Int J Clin Exp Pathol. 2013;6(8):1658\u201364.","journal-title":"Int J Clin Exp Pathol"},{"issue":"6","key":"998_CR34","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/0092-8674(94)90041-8","volume":"79","author":"T Wagner","year":"1994","unstructured":"Wagner T, Wirth J, Meyer J, Zabel B, Held M, Zimmer J, et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell. 1994;79(6):1111\u201320.","journal-title":"Cell"},{"issue":"5","key":"998_CR35","doi-asserted-by":"publisher","first-page":"G1108","DOI":"10.1152\/ajpgi.00004.2009","volume":"296","author":"EJ Formeister","year":"2009","unstructured":"Formeister EJ, Sionas AL, Lorance DK, Barkley CL, Lee GH, Magness ST. Distinct SOX9 levels differentially mark stem\/progenitor populations and enteroendocrine cells of the small intestine epithelium. Am J Physiol Gastrointest Liver Physiol. 2009;296(5):G1108\u201318.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"998_CR36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1523-1747.2000.00068.x","volume":"115","author":"UB Hofmann","year":"2000","unstructured":"Hofmann UB, Westphal JR, Van Muijen GN, Ruiter DJ. Matrix metalloproteinases in human melanoma. J Invest Dermatol. 2000;115(3):337\u201344.","journal-title":"J Invest Dermatol"},{"issue":"48","key":"998_CR37","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1038\/onc.2009.272","volume":"28","author":"JS Blackburn","year":"2009","unstructured":"Blackburn JS, Liu I, Coon CI, Brinckerhoff CE. A matrix metalloproteinase-1\/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis. Oncogene. 2009;28(48):4237\u201348.","journal-title":"Oncogene"},{"issue":"4","key":"998_CR38","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/ijc.1636","volume":"97","author":"J Nikkola","year":"2002","unstructured":"Nikkola J, Vihinen P, Vlaykova T, Hahka-Kemppinen M, Kahari VM, Pyrhonen S. High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma. Int J Cancer. 2002;97(4):432\u20138.","journal-title":"Int J Cancer"},{"issue":"2","key":"998_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056824","volume":"8","author":"N Felli","year":"2013","unstructured":"Felli N, Felicetti F, Lustri AM, Errico MC, Bottero L, Cannistraci A, et al. miR-126&126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma. PLoS One. 2013;8(2):e56824.","journal-title":"PLoS One"},{"issue":"8","key":"998_CR40","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1158\/0008-5472.CAN-07-5154","volume":"68","author":"A Gutierrez-Fernandez","year":"2008","unstructured":"Gutierrez-Fernandez A, Fueyo A, Folgueras AR, Garabaya C, Pennington CJ, Pilgrim S, et al. Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion. Cancer Res. 2008;68(8):2755\u201363.","journal-title":"Cancer Res"},{"key":"998_CR41","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12967-014-0342-7","volume":"12","author":"D Moogk","year":"2014","unstructured":"Moogk D, da Silva IP, Ma MW, Friedman EB, de Miera EV, Darvishian F, et al. Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy. J Transl Med. 2014;12:342.","journal-title":"J Transl Med"},{"issue":"4","key":"998_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035058","volume":"7","author":"J Zhong","year":"2012","unstructured":"Zhong J, Baquiran JB, Bonakdar N, Lees J, Ching YW, Pugacheva E, et al. NEDD9 stabilizes focal adhesions, increases binding to the extra-cellular matrix and differentially effects 2D versus 3D cell migration. PLoS One. 2012;7(4):e35058.","journal-title":"PLoS One"},{"issue":"7","key":"998_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069304","volume":"8","author":"JB Baquiran","year":"2013","unstructured":"Baquiran JB, Bradbury P, O'Neill GM. Tyrosine Y189 in the substrate domain of the adhesion docking protein NEDD9 is conserved with p130Cas Y253 and regulates NEDD9-mediated migration and focal adhesion dynamics. PLoS One. 2013;8(7):e69304.","journal-title":"PLoS One"},{"issue":"2\u20133","key":"998_CR44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.bbamcr.2004.04.007","volume":"1692","author":"MA Wozniak","year":"2004","unstructured":"Wozniak MA, Modzelewska K, Kwong L, Keely PJ. Focal adhesion regulation of cell behavior. Biochim Biophys Acta. 2004;1692(2\u20133):103\u201319.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"998_CR45","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1083\/jcb.200708194","volume":"180","author":"Y Lim","year":"2008","unstructured":"Lim Y, Lim ST, Tomar A, Gardel M, Bernard-Trifilo JA, Chen XL, et al. PyK2 and FAK connections to p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal adhesion formation, and cell motility. J Cell Biol. 2008;180(1):187\u2013203.","journal-title":"J Cell Biol"},{"issue":"45","key":"998_CR46","doi-asserted-by":"publisher","first-page":"18289","DOI":"10.1073\/pnas.1108993108","volume":"108","author":"BK Chauhan","year":"2011","unstructured":"Chauhan BK, Lou M, Zheng Y, Lang RA. Balanced Rac1 and RhoA activities regulate cell shape and drive invagination morphogenesis in epithelia. Proc Natl Acad Sci U S A. 2011;108(45):18289\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"998_CR47","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/ncb2535","volume":"14","author":"O Shakhova","year":"2012","unstructured":"Shakhova O, Zingg D, Schaefer SM, Hari L, Civenni G, Blunschi J, et al. Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma. Nat Cell Biol. 2012;14(8):882\u201390.","journal-title":"Nat Cell Biol"},{"issue":"21","key":"998_CR48","doi-asserted-by":"publisher","first-page":"30166","DOI":"10.18632\/oncotarget.7379","volume":"7","author":"S Ashkenazi","year":"2016","unstructured":"Ashkenazi S, Ortenberg R, Besser M, Schachter J, Markel G. SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells. Oncotarget. 2016;7(21):30166\u201377.","journal-title":"Oncotarget"},{"issue":"5","key":"998_CR49","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1172\/JCI78815","volume":"126","author":"F Ma","year":"2016","unstructured":"Ma F, Ye H, He HH, Gerrin SJ, Chen S, Tanenbaum BA, et al. SOX9 drives WNT pathway activation in prostate cancer. J Clin Invest. 2016;126(5):1745\u201358.","journal-title":"J Clin Invest"},{"issue":"2","key":"998_CR50","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bbrc.2015.03.012","volume":"460","author":"K Hiraoka","year":"2015","unstructured":"Hiraoka K, Hayashi T, Kaneko R, Nasu-Nishimura Y, Koyama-Nasu R, Kawasaki Y, et al. SOX9-mediated upregulation of LGR5 is important for glioblastoma tumorigenicity. Biochem Biophys Res Commun. 2015;460(2):216\u201321.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"998_CR51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.stem.2015.05.008","volume":"17","author":"JC Larsimont","year":"2015","unstructured":"Larsimont JC, Youssef KK, Sanchez-Danes A, Sukumaran V, Defrance M, Delatte B, et al. Sox9 controls self-renewal of oncogene targeted cells and links tumor initiation and invasion. Cell Stem Cell. 2015;17(1):60\u201373.","journal-title":"Cell Stem Cell"},{"key":"998_CR52","doi-asserted-by":"crossref","unstructured":"Zhou H, Qin Y, Ji S, Ling J, Fu J, Zhuang Z, et al. SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer. Oncogene. 2018;37(7):912\u201323.","DOI":"10.1038\/onc.2017.393"},{"issue":"31","key":"998_CR53","doi-asserted-by":"publisher","first-page":"31241","DOI":"10.18632\/oncotarget.5160","volume":"6","author":"Y Hong","year":"2015","unstructured":"Hong Y, Chen W, Du X, Ning H, Chen H, Shi R, et al. Upregulation of sex-determining region Y-box 9 (SOX9) promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma. Oncotarget. 2015;6(31):31241\u201354.","journal-title":"Oncotarget"},{"issue":"50","key":"998_CR54","doi-asserted-by":"publisher","first-page":"82228","DOI":"10.18632\/oncotarget.10573","volume":"7","author":"C Prevostel","year":"2016","unstructured":"Prevostel C, Rammah-Bouazza C, Trauchessec H, Canterel-Thouennon L, Busson M, Ychou M, et al. SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt\/ss-catenin signaling. Oncotarget. 2016;7(50):82228\u201343.","journal-title":"Oncotarget"},{"issue":"5","key":"998_CR55","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1359\/jbmr.1999.14.5.757","volume":"14","author":"WF Xie","year":"1999","unstructured":"Xie WF, Zhang X, Sakano S, Lefebvre V, Sandell LJ. Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9. J Bone Miner Res. 1999;14(5):757\u201363.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"998_CR56","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.gendis.2014.09.004","volume":"1","author":"A Jo","year":"2014","unstructured":"Jo A, Denduluri S, Zhang B, Wang Z, Yin L, Yan Z, et al. The versatile functions of Sox9 in development, stem cells, and human diseases. Genes Dis. 2014;1(2):149\u201361.","journal-title":"Genes Dis"},{"issue":"6","key":"998_CR57","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.jid.2016.02.803","volume":"136","author":"F Rambow","year":"2016","unstructured":"Rambow F, Bechadergue A, Luciani F, Gros G, Domingues M, Bonaventure J, et al. Regulation of melanoma progression through the TCF4\/miR-125b\/NEDD9 Cascade. J Invest Dermatol. 2016;136(6):1229\u201337.","journal-title":"J Invest Dermatol"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-018-0998-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-018-0998-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-018-0998-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T19:14:59Z","timestamp":1578942899000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-018-0998-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,14]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["998"],"URL":"https:\/\/doi.org\/10.1186\/s13046-018-0998-6","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,14]]},"assertion":[{"value":"18 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Committee on the Use of Live Animals in Teaching and Research in the University of Hong Kong (CULATR no: 4005\u201316) approved all the experimental procedure involving animal experimentation.Surgically procured tumor samples from patients with nevus, primary cutaneous and metastatic melanomas were obtained in the Department of Anesthesiology, Zhejiang Cancer Hospital and Department of Pediatric Surgery, the Second Hospital of Hebei Medical University with informed patients\u2019 consent for research purposes.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"17"}}